Results for tag: "Hepatoma Drug"

The Hepatoma Drug market is a subset of the larger Liver Cancer Drugs market. It is composed of drugs used to treat hepatoma, a type of liver cancer. These drugs are typically used in combination with other treatments such as surgery, radiation, and chemotherapy. Commonly used drugs include sorafenib, lenvatinib, and regorafenib. These drugs are designed to target specific proteins and pathways that are involved in the growth and spread of hepatoma cells. The Hepatoma Drug market is highly competitive, with many companies developing and marketing drugs for the treatment of hepatoma. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Other companies such as AstraZeneca, Eli Lilly, and GlaxoSmithKline also have a presence in the market. Show Less Read more